| Dr Yariv Cohen, MD | |
|
3650 Piper Street Ste A., Anchorage, AK 99508 | |
| (907) 222-4624 | |
| (907) 222-4651 |
| Full Name | Dr Yariv Cohen |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 3650 Piper Street Ste A., Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154396034 | NPI | - | NPPES |
| F100093070 | Other | IL | MEDICARE PTAN |
| 036104855 | Medicaid | IL | |
| 1615419 | Other | IL | BCBS |
| CN0576 | Other | GR NUMBER | |
| P00078265 | Other | RRMC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 036100829 (Illinois) | Secondary |
| 2086S0129X | Surgery - Vascular Surgery | MEDS7917 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Providence Kodiak Island Medical Ctr | Kodiak, AK | Hospital |
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Radiology Associates Inc | 0648182725 | 19 |
| Alaska Radiology Associates Inc | 0648182725 | 19 |
| Imaging Associates Llc | 4284641986 | 18 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Entity Name | Metropolitan Advanced Radiological Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689613804 PECOS PAC ID: 7315849817 Enrollment ID: O20040124000072 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Entity Name | Cal Devon Urgent Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104940618 PECOS PAC ID: 6507939204 Enrollment ID: O20080818000783 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Entity Name | Physicians Medical Imaging Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093148462 PECOS PAC ID: 0840434171 Enrollment ID: O20131113002055 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Entity Name | Alaska Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803214 PECOS PAC ID: 0648182725 Enrollment ID: O20240104003363 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Entity Name | Saint Vincent Radiological Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366482093 PECOS PAC ID: 1850365578 Enrollment ID: O20240315002325 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yariv Cohen, MD 3650 Piper Street Ste A., Anchorage, AK 99508 Ph: (907) 222-4624 | Dr Yariv Cohen, MD 3650 Piper Street Ste A., Anchorage, AK 99508 Ph: (907) 222-4624 |
News Archive
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain-or tuberculosis meningitis (TBM)-is often deadly, always hard to treat, and a particular threat to young children.
Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.
Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 9 days ago
Dr. Bijiibaa' K Garrison, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 520-390-8275 | |
Dr. Jeffrey Charles Congdon, MD Surgery Medicare: Medicare Enrolled Practice Location: 2925 Debarr Rd, Anchorage, AK 99508 Phone: 907-257-4869 | |
Kevin Joseph Stange, MD Surgery Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Regina Sutton Chennault, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2751 Debarr Rd, Suite 280a, Anchorage, AK 99508 Phone: 907-222-6888 Fax: 907-222-6884 | |
Mark James Thorndike, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Priya Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 Laurel St Ste 204, Anchorage, AK 99508 Phone: 907-562-8346 | |
Dr. Madhu Prasad, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2925 Debarr Rd Ste D350, Anchorage, AK 99508 Phone: 907-276-3676 Fax: 907-276-3679 |